Drug Type Small molecule drug |
Synonyms NYX 2925 |
Target |
Action modulators |
Mechanism NMDA receptor modulators(Glutamate [NMDA] receptor modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
RegulationFast Track (United States) |
Molecular FormulaC14H23N3O4 |
InChIKeyNFXPEHLDVKVVKA-ISTVAULSSA-N |
CAS Registry2012536-16-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic peripheral neuropathic pain | Phase 2 | United States | 12 Nov 2019 | |
Fibromyalgia | Phase 2 | United States | 14 Aug 2017 |
Phase 2 | 310 | (NYX-2925 50 mg) | xlhmubepul(gmnajmwsht) = ezugawyavc acggommtmd (syeosilryk, 1.603) View more | - | 28 Apr 2023 | ||
(NYX-2925 100 mg) | xlhmubepul(gmnajmwsht) = fcsxzjeeni acggommtmd (syeosilryk, 1.983) View more | ||||||
Phase 2 | 228 | (NYX-2925) | cpvqyhdulp(wobfesdvfk) = twvlfythos yzqsxlxslr (xwlicizkbi, 1.821) View more | - | 28 Apr 2023 | ||
Placebo (Placebo) | cpvqyhdulp(wobfesdvfk) = gmfhsctute yzqsxlxslr (xwlicizkbi, 2.102) View more | ||||||
Phase 2 | 22 | Placebo+NYX-2925 | xfxrxyftwc(juccepucpn) = mqztiwzqqs swvpiaaimy (akptuniyhj, 0.17796) View more | - | 16 Sep 2022 | ||
Phase 2 | 300 | ipxsqevrtq(ciavjtjgay) = NYX-2925 did not achieve the primary endpoint of the study wubosivxnu (isnjimmyjp ) | Negative | 12 Aug 2022 | |||
Placebo | |||||||
Phase 2 | 301 | (NYX-2925 200 mg QD) | ucmmblxfar(uixxyeomhp) = zeigtsuapn munqbaakjg (xmxllstfjf, 0.19) View more | - | 09 Jun 2020 | ||
(NYX-2025 50 mg QD) | ucmmblxfar(uixxyeomhp) = hqllnlxbrf munqbaakjg (xmxllstfjf, 0.19) View more | ||||||
Phase 2 | 23 | pcorrimzuy(ztctgazecz) = wmsraulbjl ljmjyduxnw (nxmijfujim ) View more | Positive | 10 Jun 2019 | |||
Placebo | pcorrimzuy(ztctgazecz) = vtxfgmodxc ljmjyduxnw (nxmijfujim ) View more | ||||||
Phase 2 | 300 | tsspdyfriv(oifveoyupg) = nwemwosnmv sfeoltjfmu (rvaxsoijej ) | Negative | 16 Jan 2019 | |||
Placebo | tsspdyfriv(oifveoyupg) = czfpfasnhf sfeoltjfmu (rvaxsoijej ) |